79 related articles for article (PubMed ID: 11766349)
21. BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.
le Coutre P; Reinke P; Neuhaus R; Trappe R; Ringel F; Lalancette M; Hemmati PG; Dörken B; Daniel PT
Eur J Haematol; 2010 Jan; 84(1):26-33. PubMed ID: 19799626
[TBL] [Abstract][Full Text] [Related]
22. Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients.
Tardieu S; Brun-Strang C; Berthaud P; Michallet M; Guilhot F; Rousselot P; Sambuc R
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):545-53. PubMed ID: 15534856
[TBL] [Abstract][Full Text] [Related]
23. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
24. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
25. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
26. [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng FY; Zheng WY; Liu XL; Xu B; Song LL; Zhang Y; Huang F
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1149-50. PubMed ID: 14625174
[TBL] [Abstract][Full Text] [Related]
27. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
[TBL] [Abstract][Full Text] [Related]
29. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
Kulikov SM; Vinogradova OIu; Chelysheva EIu; Tishchenko IA; Galaĭko MA; Lazareva OV; Senderova OM; Pepeliaeva VM; Meresiĭ SV; Luchinin AS; Ovsepian VA; Miliutina GI; Gavrilova LV; Avdeeva LB; Neverova AL; Turkina AG
Ter Arkh; 2014; 86(7):24-30. PubMed ID: 25314774
[TBL] [Abstract][Full Text] [Related]
30. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
Radivoyevitch T; Hoel DG
Radiat Environ Biophys; 2000 Sep; 39(3):153-9. PubMed ID: 11095145
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
Bhattacharyya PK
Indian J Pathol Microbiol; 2013; 56(3):188-9. PubMed ID: 24152491
[TBL] [Abstract][Full Text] [Related]
32. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.
Rohrbacher M; Berger U; Hochhaus A; Metzgeroth G; Adam K; Lahaye T; Saussele S; Müller MC; Hasford J; Heimpel H; Hehlmann R
Leukemia; 2009 Mar; 23(3):602-4. PubMed ID: 18784744
[No Abstract] [Full Text] [Related]
33. Epidemiology of chronic myeloid leukaemia: an update.
Höglund M; Sandin F; Simonsson B
Ann Hematol; 2015 Apr; 94 Suppl 2():S241-7. PubMed ID: 25814090
[TBL] [Abstract][Full Text] [Related]
34. Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries.
Radivoyevitch T
Radiat Environ Biophys; 2021 Mar; 60(1):41-47. PubMed ID: 33125593
[TBL] [Abstract][Full Text] [Related]
35. Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada.
Nguyen LT; Guo M; Naugler C; Rashid-Kolvear F
BMC Res Notes; 2018 Nov; 11(1):780. PubMed ID: 30382890
[TBL] [Abstract][Full Text] [Related]
36. Quantitative modeling of chronic myeloid leukemia: insights from radiobiology.
Radivoyevitch T; Hlatky L; Landaw J; Sachs RK
Blood; 2012 May; 119(19):4363-71. PubMed ID: 22353999
[TBL] [Abstract][Full Text] [Related]
37. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal.
Aguiar RC
Leuk Lymphoma; 1998 Mar; 29(1-2):17-26. PubMed ID: 9638972
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in the incidence of chronic myeloid leukemia.
Radivoyevitch T; Jankovic GM; Tiu RV; Saunthararajah Y; Jackson RC; Hlatky LR; Gale RP; Sachs RK
Radiat Environ Biophys; 2014 Mar; 53(1):55-63. PubMed ID: 24337217
[TBL] [Abstract][Full Text] [Related]
39. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Gunnarsson N; Sandin F; Höglund M; Stenke L; Björkholm M; Lambe M; Olsson-Strömberg U; Richter J; Själander A
Eur J Haematol; 2016 Oct; 97(4):387-92. PubMed ID: 26833713
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloid leukemia: Two mysteries.
Radivoyevitch T; Jorgensen TN; Lindner DJ; Maciejewski JP; Miyazaki Y; Gale RP
Leuk Res; 2019 Apr; 79():3-5. PubMed ID: 30780032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
